Hims & Hers Health, Inc. (HIMS) Outpaces Stock Market Gains: What You Should Know [Yahoo! Finance]
Hims & Hers Health, Inc. Class A (HIMS)
Company Research
Source: Yahoo! Finance
The stock outpaced the S&P 500's daily gain of 0.77%. On the other hand, the Dow registered a gain of 0.49%, and the technology-centric Nasdaq increased by 0.95%. The the stock of company has risen by 63.01% in the past month, leading the Medical sector's gain of 1.49% and the S&P 500's gain of 3.71%. The investment community will be paying close attention to the earnings performance of Hims & Hers Health, Inc. in its upcoming release. The company's upcoming EPS is projected at $0.05, signifying a 266.67% increase compared to the same quarter of the previous year. Meanwhile, the latest consensus estimate predicts the revenue to be $295.32 million, indicating a 42.04% increase compared to the same quarter of the previous year. For the entire fiscal year, the Zacks Consensus Estimates are projecting earnings of $0.18 per share and a revenue of $1.23 billion, representing changes of +263.64% and +40.58%, respectively, from the prior year. Investors should also note any recent cha
Show less
Read more
Impact Snapshot
Event Time:
HIMS
Last Price
Price Change
Price Change%
Volume Shares
Max Up
Max Down
%
Volume Ratio
Performance Comparison
Updated
|
Event Day
Stock performance from the time of news release until the following 4pm ET market close
|
Last price at news event
|
Since Event
Multi-day stock performance from the time of the news release
|
|---|---|---|
|
EVENT DAY
Stock performance from the time of news release until the following 4pm ET market close
|
LAST
PRICE AT NEWS EVENT |
SINCE EVENT
Multi-day stock performance from the time of the news release
|
| Last Price | ||
| VWAP | ||
|
High:
|
Max Up |
High:
|
|
Low:
|
Max Down |
Low:
|
|
%
|
Post news range |
%
|
|
|
Price change |
|
|
|
Price Change Percentage |
|
|
|
S&P 500 (SPX) |
|
|
%
|
Volume ratio |
%
|
| Volume | ||
| Ticks | ||
|
|
Avg transaction size |
|
Don't Miss Out On The Next BIG Stock Move
Event day
Event Day Chart will not be displayed beyond 90-day period of the event
Performance since event
Time And Velocity Analysis
Be the first to know
Opt in for alerts from News Quantifed
Sign Up Today
Opt-in for
HIMS alerts
Learn More With NQ
Reading the Impact Report
Help Me Understand This Data
Help Me Understand This Data
How NQ Works
What is news-based trading?
And why is it so successful?
And why is it so successful?
Movers & Shakers
The biggest gainers and losers and WHY it moved
HIMS alerts
High impacting Hims & Hers Health, Inc. Class A news events
Weekly update
A roundup of the hottest topics
HIMS
News
- Hims & Hers Health, Inc. (HIMS) Rises Higher Than Market: Key Facts [Yahoo! Finance]Yahoo! Finance
- Hims & Hers offers compounded Wegovy for $99 a month to select professions [Yahoo! Finance]Yahoo! Finance
- Hims & Hers offers compounded Wegovy for $99 a month to select professions [Yahoo! Finance]Yahoo! Finance
- Hims & Hers to Offer Access to Compounded GLP-1 Injections for as Low as $99/Month to U.S. Military, Veterans, Teachers, Nurses and First RespondersBusiness Wire
- 3 US Insider Picks With Earnings Growth Up To 98% [Yahoo! Finance]Yahoo! Finance
HIMS
Earnings
- 8/5/24 - Beat
HIMS
Sec Filings
- 9/23/24 - Form 4
- 9/23/24 - Form 4
- 9/20/24 - Form 144
- HIMS's page on the SEC website